JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B3041 BTB06584

Target: F1 Fo-ATPase

Summary: F1F0 ATP synthases

≥17.05 mg/mL
B1402 GZD824

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor,novel orally bioavailable

≥36.25 mg/mL
B1499 RVX-208
2 Citation

Summary: Potent BET bromodomain inhibitor

insoluble in H2O; ≥18.52 mg/mL
B3272 Inauhzin

Target: Sir2-like Family Deacetylases (Sirtuins)

Summary: SIRT1 inhibitor

≥23.5 mg/mL
B1526 Tandutinib (MLN518)

Summary: FLT3 inhibitor,potent and selective

≥17.85 mg/mL
B1032 VU0152100

Summary: M4 receptor allosteric modulators

Soluble in DMSO
B1586 IKK-16 (IKK Inhibitor VII)
1 Citation

Summary: Selective IκB kinase inhibitor

≥23.05 mg/mL
L1045 DiscoveryProbe™ TGF-beta/Smad Compound Library

Summary: A unique collection of 88 TGF-beta/Smad inhibitors for TGF-beta/Smad signaling pathway research.
B6134 Amodiaquine dihydrochloride dihydrate

Summary: histamine N-methyl transferase inhibitor

≥18.03 mg/mL
B7814 ATI-2341 TFA

Summary: CXCR4 allosteric agonist

Soluble in DMSO